Prentiss Smith & CO Inc Gsk PLC Transaction History

Prentiss Smith & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$37.8 - $42.69 $17,652 - $19,936	-467 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$39.75 - $42.69 $19,875 - $21,345	-500 Reduced 51.71%	467 $19,000
Q1 2018 Apr 20, 2018	BUY	$36.18 - $40.15 $34,986 - $38,825	967 New	967 $38,000
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $34,173 - $40,517	-967 Closed	0 $0
Q3 2017 May 03, 2018	BUY	$39.44 - $41.55 $38,138 - $40,178	967	967 $39,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.1B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Prentiss Smith & CO Inc with notifications on news.